BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38037472)

  • 1. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
    Lago C; Federico A; Leva G; Mack NL; Schwalm B; Ballabio C; Gianesello M; Abballe L; Giovannoni I; Reddel S; Rossi S; Leone N; Carai A; Mastronuzzi A; Bisio A; Soldano A; Quintarelli C; Locatelli F; Kool M; Miele E; Tiberi L
    EMBO Mol Med; 2023 Dec; 15(12):e18199. PubMed ID: 38037472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
    Xu X; Kumari R; Zhou J; Chen J; Mao B; Wang J; Zheng M; Tu X; An X; Chen X; Zhang L; Tian X; Wang H; Dong X; Bao Z; Guo S; Ouyang X; Shang L; Wang F; Yan X; Zhang R; Vries RGJ; Clevers H; Li QX
    PLoS One; 2023; 18(1):e0279821. PubMed ID: 36602988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
    Kopper O; de Witte CJ; Lõhmussaar K; Valle-Inclan JE; Hami N; Kester L; Balgobind AV; Korving J; Proost N; Begthel H; van Wijk LM; Revilla SA; Theeuwsen R; van de Ven M; van Roosmalen MJ; Ponsioen B; Ho VWH; Neel BG; Bosse T; Gaarenstroom KN; Vrieling H; Vreeswijk MPG; van Diest PJ; Witteveen PO; Jonges T; Bos JL; van Oudenaarden A; Zweemer RP; Snippert HJG; Kloosterman WP; Clevers H
    Nat Med; 2019 May; 25(5):838-849. PubMed ID: 31011202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.
    Aizawa Y; Takada K; Aoyama J; Sano D; Yamanaka S; Seki M; Kuze Y; Ramilowski JA; Okuda R; Ueno Y; Nojima Y; Inayama Y; Hatakeyama H; Hatano T; Takahashi H; Nishimura G; Fujii S; Suzuki Y; Taniguchi H; Oridate N
    Cell Oncol (Dordr); 2023 Apr; 46(2):409-421. PubMed ID: 36538240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
    Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
    STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
    Pamarthy S; Sabaawy HE
    Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of patient-derived organoid models of lower-grade glioma.
    Abdullah KG; Bird CE; Buehler JD; Gattie LC; Savani MR; Sternisha AC; Xiao Y; Levitt MM; Hicks WH; Li W; Ramirez DMO; Patel T; Garzon-Muvdi T; Barnett S; Zhang G; Ashley DM; Hatanpaa KJ; Richardson TE; McBrayer SK
    Neuro Oncol; 2022 Apr; 24(4):612-623. PubMed ID: 34850183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation, Expansion, and Biobanking of Gastrointestinal Patient-Derived Organoids from Tumor and Normal Tissues.
    Cabeza-Segura M; Garcia-Micó B; Cervantes A; Castillo J
    Methods Mol Biol; 2024; 2777():123-133. PubMed ID: 38478340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
    Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
    Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy.
    Yoon C; Lu J; Kim BJ; Cho SJ; Kim JH; Moy RH; Ryeom SW; Yoon SS
    J Gastrointest Surg; 2023 Apr; 27(4):666-676. PubMed ID: 36627466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.
    Fusco P; Parisatto B; Rampazzo E; Persano L; Frasson C; Di Meglio A; Leslz A; Santoro L; Cafferata B; Zin A; Cimetta E; Basso G; Esposito MR; Tonini GP
    BMC Cancer; 2019 Oct; 19(1):970. PubMed ID: 31638925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling.
    Van Hemelryk A; Tomljanovic I; de Ridder CMA; Stuurman DC; Teubel WJ; Erkens-Schulze S; Verhoef EI; Remmers S; Mahes AJ; van Leenders GJLH; van Royen ME; van de Werken HJG; Grudniewska M; Jenster GW; van Weerden WM
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy.
    Wu W; Li X; Yu S
    Acta Biomater; 2022 Jul; 146():23-36. PubMed ID: 35533925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening.
    Cui R; Duan H; Hu W; Li C; Zhong S; Liang L; Chen S; Hu H; He Z; Wang Z; Guo X; Chen Z; Xu C; Zhu Y; Chen Y; Sai K; Yang Q; Guo C; Mou Y; Jiang X
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38656317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
    Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
    Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.
    Ding L; Yang Y; Lu Q; Cao Z; Weygant N
    Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses.
    de Witte CJ; Espejo Valle-Inclan J; Hami N; Lõhmussaar K; Kopper O; Vreuls CPH; Jonges GN; van Diest P; Nguyen L; Clevers H; Kloosterman WP; Cuppen E; Snippert HJG; Zweemer RP; Witteveen PO; Stelloo E
    Cell Rep; 2020 Jun; 31(11):107762. PubMed ID: 32553164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.